Log in to your Inderes Free account to see all free content on this page.
Lumito
3.28 SEK
+3.14 %
Less than 1K followers
LUMITO
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+3.14 %
-25.11 %
-56.27 %
-53.14 %
-87.38 %
-95.09 %
-99.05 %
-99.18 %
-98.65 %
Lumito is a Swedish company that develops and markets systems for tissue and biomarker analysis in digital pathology, built on upconverting nanoparticle technology. The company targets healthcare facilities, research and the pharmaceutical sector. The company was formed in 2010 as a spinoff from a research group at Lund University's Department of Atomic Physics and Laser Center. Lumito is headquartered in Lund.
Read moreMarket cap
11.29M SEK
Turnover
64.41K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
7.5.
2026
General meeting '26
7.5.
2026
Interim report Q1'26
20.8.
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Lumito and OracleBio initiate a pilot project to explore the combination of high-sensitivity tissue imaging and advanced image analysis
Lumito and Tethis complete proof-of-concept study demonstrating compatibility between Lumito’s UCNP imaging and Tethis’ SmartBioSurface® slides
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio